Market Overview

UPDATE: Piper Jaffray Downgrades Meredith Corporation to Neutral on Full Valuation

Share:
Related MDP
Wall Street's M&A Chatter From April 12: Square, Meredith-Time, PPG-AkzoNobel
Wall Street's M&A Chatter From March 24-26: Time Inc, Lattice Semiconductor, Evolent Health

Piper Jaffray downgraded Meredith Corporation (NYSE: MDP) from Overweight to Neutral and raised the price target from $38.00 to $43.00.

Piper Jaffray stated, "We are assuming coverage of Meredith with a Neutral rating and $43 PT as shares appear fairly valued on core fundamentals, in our view, following 41% appreciation the last 3 months. We acknowledge intrigue around value creation associated with a potential spin-off of Time's magazines with Meredith, with our scenario analysis suggesting fair valuation could reach $66 with modest cost synergies. However, given complexity and risk we can only place a 50/50 probability on a completed transaction, and we would wait for more clarity on details surrounding a spin-off to get constructive on the stock."

Meredith Corporation closed at $42.56 on Monday.

Latest Ratings for MDP

DateFirmActionFromTo
Mar 2017BenchmarkMaintainsHold
Jan 2017BenchmarkDowngradesBuyHold
Jan 2016FBR CapitalMaintainsMarket Perform

View More Analyst Ratings for MDP
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Downgrades Analyst Ratings

 

Related Articles (MDP)

View Comments and Join the Discussion!